RAPA-501-Allo Therapy of COVID-19-ARDS
Clinical trial NCT04482699 · TERMINATED
Trial details
- NCT number
- NCT04482699
- Sponsor
- Rapa Therapeutics LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2021-09-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.